Advertisement

Topics

Latest "Centre Partners" News Stories - Page: 20

01:56 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "Centre Partners" found in our extensive news archives from over 250 global news sources.

More Information about Centre Partners on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Centre Partners for you to read. Along with our medical data and news we also list Centre Partners Clinical Trials, which are updated daily. BioPortfolio also has a large database of Centre Partners Companies for you to search.

Showing "Centre Partners" News Articles 476–500 of 5,500+

Probably Relevant

£7 million Research and Development boost for North West businesses

Lancaster University is launching a £7.1 million low-carbon research and development programme to support small and medium sized enterprises (SMEs) in Lancashire, Cumbria, Cheshire and Liverpool.The award-winning Centre for Global Eco-Innovation, at Lancaster University, returns with more than 50 long-term projects involving three-year PhD, or one-year Master degree, high-calibre graduate re...


Das London Psychiatry Centre: Lebensverändernde Entdeckung für Patienten mit bipolarer Störung

LONDON, December 20, 2018 /PRNewswire/ -- Eine bahnbrechende Entdeckung ermöglicht es einer bestimmten Gruppe von Patienten mit bipolaren Störungen, eine wirksame Behandlung mit minimalen oder Read more...

Nanoparticles Help Detect Deep-tissue Cancers

NewsResearchers have developed a new form of nanoparticle and associated imaging technique that can detect multiple disease biomarkers, including those for breast cancer, found in deep-tissue in the body.


$AZN provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV #NSCLC #Fail https://www.astrazeneca.com/media-centre/press-releases/2018/astrazeneca-provides-update-on-the-phase-iii-mystic-trial-of-imfinzi-and-tremelimumab-in-s

$AZN provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV #NSCLC #Fail https://www.astrazeneca.com/media-centre/press-releases/2018/astrazeneca-provides-update-on-the-phase-iii-mystic-trial-of-imfinzi-and-tremelimumab-in-stage-iv-non-small-cell-lung-cancer

Pfizer partners with CytoReason on immune system models for drug discovery

Israeli-machine learning company CytoReason has announced it has signed a collaboration agreement with Pfizer in which the latter will leverage...Read More... The post Pfizer partners with CytoReason on immune system models for drug discovery appeared first on Pharmaceutical Technology.

Nurocor partners with Intilaris to improve clinical trial planning process

US-based data repository provider Nurocor has partnered with Swiss Intilaris LifeSciences, a consultancy working to optimise drug development, to enhance...Read More... The post Nurocor partners with Intilaris to improve clinical trial planning process appeared first on Pharmaceutical Technology.

Research Reveals How Ancient Viruses Got Cannabis High

A study conducted at the University of Toronto (UT) has produced the world's first chromosome map of cannabis, revealing the plant's evolutionary past and points to its future as potential medicine. The researchers from UT's Donnelly Centre found that THC and CBD, bioactive substances produced by cannabis and sought by medical patients and recreati...

Bellus Health grosses $Cdn35mm via private financing

Bellus Health Inc. grossed $Cdn35mm ($26.2mm) through the overnight marketed equity offering of 36.8mm common shares at $Cdn0...

Advancing Medical Technology in the Atlantic Area

Bionow is working within a consortium of seven world-class partners in the Atlantic Area who have expertise in the six Key Enabling Technologies (KETs) that have a wide range of product applications: micro and nano electronics, nanotechnology, industrial biotechnology, advanced materials, photonics and advanced manufacturing technologies. The project will also embrace Industrie 4.0, also known as...

Merck partners with Cyclica for AI-based screening of drug targets

Merck has signed an agreement to licence Canadian Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its...Read More... The post Merck partners with Cyclica for AI-based screening of drug targets appeared first on Pharmaceutical Technology.

Ascentage closes $150mm Series C round

Ascentage Pharma Group Corp. Ltd. raised $150mm through its Series C round. Existing backers YuanMing Prudence Fund and Oriza...

Thrifty White, PrescribeWellness expand offering to affiliated pharmacy partners

Exosomes Involved In Spreading Of Glioblastoma

Link between what we see and how we remember 'breaks' as we get older

(Baycrest Centre for Geriatric Care) Forgetfulness and age-related memory lapses are a common complaint among older adults, but what is still not understood is what causes these changes. Recent research published by scientists at Baycrest's Rotman Research Institute (RRI) brings us a step closer to uncovering the answer, which could help with distinguishing signs of dementia earlier.

When a chemical tag makes the difference in cell fate and gene expression

(Center for Genomic Regulation) Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have uncovered the role of special chemical 'tags' in controlling vital genes involved in early mammalian development, publishing their findings in the journal Nature Genetics.

Ionis partners with Roche to advance new antisense drug

Ionis Pharmaceuticals has entered a deal worth up to $760m with Roche for further development of its antisense drug, IONIS-FB-L,...Read More... The post Ionis partners with Roche to advance new antisense drug appeared first on Pharmaceutical Technology.

Enbridge Energy Partners, L.P. and Enbridge Energy Management, L.L.C. ...

HOUSTON, Dec. 17, 2018 /PRNewswire/ - Enbridge Energy Partners, L.P. (NYSE: EEP) (EEP or the Partnership) and Enbridge Energy Management, L.L.C. (NYSE: EEQ) (EEQ) today Read more...

Digital Health Partners with RCP’s Health Informatics Unit

Digital Health has announced the Health Informatics Unit (HIU) of the Royal College of Physicians as a key partner to support the promotion of technology... The post Digital Health Partners with RCP’s Health Informatics Unit appeared first on .

FERTILITÉ MASCULINE : Elle serait à son top 3 heures après

Ces recherches du centre de médecine de la reproduction de la China Medical University (laboratoire de Li et Wang), publiées dans la revue Molecular and Cellular Proteomics, vont-elles remettre en question les conseils actuellement donnés par les médecins des cliniques de fertilité ? Aujourd’hui, on conseille en effet, aux hommes qui cherchent à concevoir de s'abstenir […]

The London Psychiatry Centre: Life-changing Discovery for Bipolar Disorder Sufferers

LONDON, December 20, 2018 /PRNewswire/ -- A groundbreaking discovery allows a specific group of bipolar disorder sufferers to receive effective treatment with minimal or no Read more...

How lobbying blocked European safety checks for dangerous medical implants

For the past decade, European lawmakers have been at the centre of a lobbying storm. Bold plans to overhaul safety regulations for the millions of medical implants embedded in patients each...

July’s top news stories

Kyoto University to begin trials of iPS cells to treat Parkinson’s Kyoto University’s Centre for iPS Cell Research and Application...Read More... The post July’s top news stories appeared first on Drug Development Technology.

Supercomputing Simulations and Machine Learning Help Improve Power Plants

NewsHPC resources and data-driven machine learning help researchers model how power plants could be retrofitted for better operation.

Festival of Genomics returns to London to help shape the future of precision medicine

London, UK, 17th December 2018 / Sciad Newswire / In January, the largest genomics event in the UK will return to London for the fourth time. The Festival of Genomics will be held in the Business Design Centre 23rd-24thJanuary 2019.

Immutep partners with Merck and Pfizer for cancer drug trial

Australian biotechnology company Immutep has signed an agreement with Merck and Pfizer to partner in a Phase I clinical trial...Read More... The post Immutep partners with Merck and Pfizer for cancer drug trial appeared first on Pharmaceutical Technology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks